These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23107479)

  • 41. Synthesis of a potent photoreactive acidic γ-secretase modulator for target identification in cells.
    Rennhack A; Jumpertz T; Ness J; Baches S; Pietrzik CU; Weggen S; Bulic B
    Bioorg Med Chem; 2012 Nov; 20(21):6523-32. PubMed ID: 23000293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
    Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amino-caprolactam derivatives as gamma-secretase inhibitors.
    Parker MF; Bronson JJ; Barten DM; Corsa JA; Du W; Felsenstein KM; Guss VL; Izzarelli D; Loo A; McElhone KE; Marcin LR; Padmanabha R; Pak R; Polson CT; Toyn JH; Varma S; Wang J; Wong V; Zheng M; Roberts SB
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5790-5. PubMed ID: 17869509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Practical asymmetric synthesis of a gamma-secretase inhibitor exploiting substrate-controlled intramolecular nitrile oxide-olefin cycloaddition.
    Scott JP; Oliver SF; Brands KM; Brewer SE; Davies AJ; Gibb AD; Hands D; Keen SP; Sheen FJ; Reamer RA; Wilson RD; Dolling UH
    J Org Chem; 2006 Apr; 71(8):3086-92. PubMed ID: 16599604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimisation of BACE1 inhibition of tripartite structures by modification of membrane anchors, spacers and pharmacophores - development of potential agents for the treatment of Alzheimer's disease.
    Linning P; Haussmann U; Beyer I; Weidlich S; Schieb H; Wiltfang J; Klafki HW; Knölker HJ
    Org Biomol Chem; 2012 Oct; 10(41):8216-35. PubMed ID: 22930158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SAR studies of acidic dual γ-secretase/PPARγ modulators.
    Hieke M; Ness J; Steri R; Greiner C; Werz O; Schubert-Zsilavecz M; Weggen S; Zettl H
    Bioorg Med Chem; 2011 Sep; 19(18):5372-82. PubMed ID: 21873070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Establishing the relationship between in vitro potency, pharmacokinetic, and pharmacodynamic parameters in a series of orally available, hydroxyethylamine-derived β-secretase inhibitors.
    Wood S; Wen PH; Zhang J; Zhu L; Luo Y; Babu-Khan S; Chen K; Pham R; Esmay J; Dineen TA; Kaller MR; Weiss MM; Hitchcock SA; Citron M; Zhong W; Hickman D; Williamson T
    J Pharmacol Exp Ther; 2012 Nov; 343(2):460-7. PubMed ID: 22911925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitors.
    Thompson LA; Shi J; Decicco CP; Tebben AJ; Olson RE; Boy KM; Guernon JM; Good AC; Liauw A; Zheng C; Copeland RA; Combs AP; Trainor GL; Camac DM; Muckelbauer JK; Lentz KA; Grace JE; Burton CR; Toyn JH; Barten DM; Marcinkeviciene J; Meredith JE; Albright CF; Macor JE
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6909-15. PubMed ID: 21974952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluoro-benzimidazole derivatives to cure Alzheimer's disease: In-silico studies, synthesis, structure-activity relationship and in vivo evaluation for β secretase enzyme inhibition.
    Ali S; Asad MHHB; Maity S; Zada W; Rizvanov AA; Iqbal J; Babak B; Hussain I
    Bioorg Chem; 2019 Jul; 88():102936. PubMed ID: 31054426
    [No Abstract]   [Full Text] [Related]  

  • 50. Carbazole-containing arylcarboxamides as BACE1 inhibitors.
    Bertini S; Asso V; Ghilardi E; Granchi C; Manera C; Minutolo F; Saccomanni G; Bortolato A; Mason J; Moro S; Macchia M
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6657-61. PubMed ID: 21986588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. γ-Secretase as a target for Alzheimer's disease.
    Wolfe MS
    Adv Pharmacol; 2012; 64():127-53. PubMed ID: 22840746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design and synthesis of novel methoxypyridine-derived gamma-secretase modulators.
    Rynearson KD; Buckle RN; Herr RJ; Mayhew NJ; Chen X; Paquette WD; Sakwa SA; Yang J; Barnes KD; Nguyen P; Mobley WC; Johnson G; Lin JH; Tanzi RE; Wagner SL
    Bioorg Med Chem; 2020 Nov; 28(22):115734. PubMed ID: 33007551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery and initial optimization of 5,5'-disubstituted aminohydantoins as potent beta-secretase (BACE1) inhibitors.
    Nowak P; Cole DC; Aulabaugh A; Bard J; Chopra R; Cowling R; Fan KY; Hu B; Jacobsen S; Jani M; Jin G; Lo MC; Malamas MS; Manas ES; Narasimhan R; Reinhart P; Robichaud AJ; Stock JR; Subrath J; Svenson K; Turner J; Wagner E; Zhou P; Ellingboe JW
    Bioorg Med Chem Lett; 2010 Jan; 20(2):632-5. PubMed ID: 19959359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thiazole-diamides as potent gamma-secretase inhibitors.
    Chen YL; Cherry K; Corman ML; Ebbinghaus CF; Gamlath CB; Liston D; Martin BA; Oborski CE; Sahagan BG
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5518-22. PubMed ID: 17764937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rac1 changes the substrate specificity of gamma-secretase between amyloid precursor protein and Notch1.
    Boo JH; Sohn JH; Kim JE; Song H; Mook-Jung I
    Biochem Biophys Res Commun; 2008 Aug; 372(4):913-7. PubMed ID: 18538664
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of gamma-secretase inhibitors efficacious in a transgenic animal model of Alzheimer's disease.
    Asberom T; Zhao Z; Bara TA; Clader JW; Greenlee WJ; Hyde LA; Josien HB; Li W; McPhail AT; Nomeir AA; Parker EM; Rajagopalan M; Song L; Wong GT; Zhang L; Zhang Q; Pissarnitski DA
    Bioorg Med Chem Lett; 2007 Jan; 17(2):511-6. PubMed ID: 17079141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Substituted thiazolamide coupled to a redox delivery system: a new gamma-secretase inhibitor with enhanced pharmacokinetic profile.
    Laras Y; Quéléver G; Garino C; Pietrancosta N; Sheha M; Bihel F; Wolfe MS; Kraus JL
    Org Biomol Chem; 2005 Feb; 3(4):612-8. PubMed ID: 15703796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia.
    Eriksson A; Höglund M; Lindhagen E; Aleskog A; Hassan SB; Ekholm C; Fhölenhag K; Jensen AJ; Löthgren A; Scobie M; Larsson R; Parrow V
    Biochem Pharmacol; 2010 Nov; 80(10):1507-16. PubMed ID: 20705060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transition metal free hydrolysis/cyclization strategy in a single pot: synthesis of fused furo N-heterocycles of pharmacological interest.
    Nakhi A; Rahman MS; Seerapu GP; Banote RK; Kumar KL; Kulkarni P; Haldar D; Pal M
    Org Biomol Chem; 2013 Aug; 11(30):4930-4. PubMed ID: 23824158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A-ring modification of SCH 900229 and related chromene sulfone γ-secretase inhibitors.
    Wu WL; Sasikumar TK; Domalski MS; Qiang L; Burnett DA; Clader J; Greenlee WJ; Chan TM; Lee J; Zhang L
    Bioorg Med Chem Lett; 2013 Feb; 23(3):850-3. PubMed ID: 23265902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.